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2020 | CARDIOVASCULAR

OUTCOMES & INNOVATION REPORT

THE MAINEHEALTH
SYSTEM

All cardiovascular procedures present unique risks, and such risks may affect a particular patient’s outcome.
Outcome report data presented in this report is from Maine Medical Center.

The photos in this report were taken prior to COVID-19 and do not reflect MaineHeath’s current masking and social distancing requirements.
PICTURED ON COVER: Sunil Malhotra, MD, Director of Congenital Heart Surgery with Barb Heyl, PA-C, and Meghan Sprague, PA-C.

CARDIOVASCULAR
SERVICES
The MaineHealth system is a partnership
of physicians and hospitals, listed below,
dedicated to improving the cardiovascular
health of the residents of northern New
England. Our vision includes being a
premier provider of accessible, cost effective,
coordinated and compassionate care; and
putting our patients’ needs first, delivering
superior clinical outcomes and excellence in
education and clinical research. The program
is committed to achieving surgical outcomes
that exceed national benchmarks.
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highlights many of our treatment offerings and leading
technologies in use across MaineHealth.

Marco Diaz, MD, was named as the new Chair of the
Department of Cardiovascular Medicine and Chief of the
MaineHealth Cardiovascular Services in early 2020. Dr. Diaz is
recognized by peers and colleagues as an outstanding clinician
and educator. For the past five years, he served as Senior
Medical Director, overseeing the development of a systemwide cardiology practice. At the same time, he has been a
primary driver in the programmatic growth of cardiac services.
Dr. Diaz continues his contribution to MMC by fostering the
clinical, educational and research growth of cardiovascular
medicine at the institution.

I am honored to be part of Cardiovascular Services at
MaineHealth — an integrated network of hospitals,
health care providers and specialists — built with patients’
needs at the very center. We provide comprehensive heart
care to Maine and Mt. Washington Valley residents
through a coordinated system designed to achieve the
best possible cardiac and vascular outcomes.
For over 60 years, we have worked diligently to become one
of the premier cardiovascular networks in New England
and the largest in northern New England. Our teams
of dedicated physicians, advanced practitioners, nurses,
clinical and technical staff and administrators takes great
pride in what they do every day to provide the best care
for patients. We have a long tradition and commitment to
empowering caregivers at all levels to provide the highest
quality patient care and service to cardiovascular patients.
Our service line combines medical and surgical services
(both inpatient and ambulatory care), along with research
and education, under unified clinical and administrative
leadership. Our intent is to highlight our strong
performance as evidenced by the data presented clearly
and transparently on the following pages. This report
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For example, MaineHealth aims to help people with
heart failure have the best possible clinical outcomes
and quality of life. To achieve this, our organizations
and partners implemented a variety of evidence-based
treatments across MaineHealth and in every care setting
in order to provide care as close to home as possible. This
approach helps patients manage heart failure symptoms
better; as a result, they need to be hospitalized less often.
Care settings include patients’ private homes, nursing care
facilities, medical care offices, emergency departments
and hospitals. Treatment options include evidence-based
clinical pathways, supporting clinical decision tools,
providing patients with clear and consistent plans of care
and specialized care for patients with advanced disease.
To enable a more seamless transition across the care
continuum, Cardiovascular Services activated our shared
electronic health record, Epic’s Cupid application, in
February 2020. I would like to thank the cardiologists
and physician leaders, along with other staff people who
dedicated their time, talent and expertise to this effort.
This large project included practice managers, support
teams and information technology teams that invested
countless hours partnering with our clinicians to ensure the
readiness of the technical infrastructure, validating clinical
and administrative workflow and training subject matter
experts. The success of this complex implementation is the
result of outstanding teamwork, project management and
leadership across our hospitals and physician practices.
I invite you to collaborate and partner with us as we
continue to strive to improve cardiovascular care,
quality and patient access, while delivering the best
health outcomes and developing a systematic approach
that serves the residents of Maine and southern New
Hampshire, as well as visitors to northern New England.
Marco Diaz, MD
Chair of the Department of Cardiovascular Medicine
Chief of MaineHealth Cardiovascular Services

“ONE PATIENT, ONE RECORD” ACROSS THE
CONTINUUM OF CARE
MaineHealth achieved an exceptional milestone
this year: the successful activation of our shared
electronic health record. The implementation of the
Epic cardiology ambulatory and Cupid applications
was the culmination of a coordinated, multifaceted
effort that engaged hundreds of dedicated leaders
and teams across our health system.
This implementation puts the patient at the center of
care. Now, any clinical caregiver of a MaineHealth
cardiac patient has access to health information in one
central location. This supports improved efficiencies,
better transitions of care and flow of patient
information and superior clinical outcomes. This
milestone implementation will bring several benefits
to providers and patients:
• Gives our cardiology care teams access to a fully
integrated health record.
• Improves medication reconciliations and patient
safety.
• Reduces variability and standardizes Epic
tools and functionality already implemented at
MaineHealth organizations.
• Gives all cardiac patients across our health system
the ability to access their health information
through MyChart.

HEALTH RECORD
FOLLOWS PATIENT
When it comes to
delivering high-quality
patient care, an integrated
electronic health record
that follows your patient
matters. Last year, Mike
Knof was out grocery
shopping in Damariscotta
Mike Knof,
when he experienced
cardiac patient
cardiac arrest and
collapsed to the ground. After receiving chest
compressions from nearby community members, he
was rushed to LincolnHealth - Miles Campus, where
the ER team stabilized him and transported him to
MMC. Mike’s medical records were already there
when he arrived.
MMC cardiologist Dr. Jeremy Estrada was part of the
cardiac team when Mike was rushed in. Because
LincolnHealth and MMC use Epic applications, Dr.
Estrada was able to see Mike’s full medical history
and medication list and to act quickly, using the
newest technology and collective expertise of his
team. He performed an angiogram and a right heart
catheterization, and also used a special kind of
imaging that revealed Mike’s blockage had not caused
a heart attack. So instead of a stent, Dr. Estrada put
in a balloon pump. “Because we were on the same
electronic health record, we could view Mike’s full
record, allowing us to anticipate and predict how
sick he was,” said Dr. Estrada. “This enabled us to
provide him with the care he needed and the care
Mike needed to heal after the procedure.”

NEW ADULT CONGENITAL CARDIOLOGY PROGRAM
People with congenital heart disease need care throughout their lives. From infancy through adulthood, people with
congenital heart issues are best served by specially trained clinicians who understand their complex and unique needs.
Our program offers a full range of inpatient and outpatient clinical services — from diagnosis to surgical repair. We care
for pediatric and adult patients with all forms of congenital heart conditions and pulmonary hypertension issues. In 2019,
MaineHealth launched a new program for adult patients with any form of congenital heart condition. This includes those
with newly diagnosed congenital heart defects, as well as those with complex congenital heart disease who may have
received care since childhood and now may require transition to adult medical services such as family planning, genetic
counseling and ongoing cardiology care.
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CARDIOVASCULAR
HIGHLIGHTS
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HEART FAILURE AND MECHANICAL CIRCULATORY SUPPORT
Our Advanced Heart Failure Program at MMC is made up of a multidisciplinary team of cardiologists, cardiac
surgeons, advanced practice providers and nurses, and supported by experts in all disciplines to manage patients
throughout all stages of heart failure. The team employs the most recent medical and surgical therapies for cardiogenic
shock and heart failure. These therapies include mechanical circulatory support devices such as extracorporeal
membrane oxygenation (ECMO), temporary percutaneous ventricular assist devices to support both the right and left
ventricles, and durable implantable left ventricular assist devices (LVAD). Durable LVADs are used to help patients
with advanced heart failure restore circulation and improve functional capacity. These devices can be employed to
sustain patients awaiting heart transplantation, as well as patients not able to receive transplants.

VOLUME
MECHANICAL CIRCULATORY SUPPORT
2017

2018

2019

LVAD IMPLANTS

14

14

10

PERCUTANEOUS LVAD

10

10

19

ECMO

20

21

29

CARDIAC ARRHYTHMIAS
The MaineHealth Cardiac Arrhythmia Program supports patients with problems in the electrical function of the
heart that cause abnormal heart rhythms (arrhythmias). The program is ever-evolving to address the changing
arrhythmia needs of our communities. MMC has become a high-volume tertiary referral center for northern
New England, managing both simple and complex arrhythmias including atrial fibrillation, supraventricular and
ventricular tachycardia, atrial flutter, premature ventricular contractions and Wolff-Parkinson-White syndrome.
MMC achievements include:
• The first hospital in Maine to perform the convergent procedure for patients suffering with persistent atrial
fibrillation (A-fib), who may have failed other treatment modalities.
• Achieved the American Heart Association’s Get with the Guidelines: A-fib Gold Award for 2019.
Our electrophysiology (EP) specialists are available for consultation at MaineHealth hospitals and practice offices
across the system service area.
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CARDIAC ARRHYTHMIA VOLUMES

52

2019

47
5

47
6
47
7

2018

7

37
0

400

0

TOTAL
ABLATIONS

AF
ABLATIONS

ICD
PACEMAKER
IMPLANTATIONS IMPLANTATIONS

LASER LEAD
EXTRACTIONS

50

39

29

36

100

25

200

48

18
5
20

6

27

300

2017

30
3
29
8

500

50

4

8

57

600

LEFT ATRIAL
APPENDAGE
OCCLUSION

MMC was the first hospital in the state to perform the convergent procedure for
patients suffering with long-standing persistent A-fib who may have failed other
treatment modalities. MMC is the only hospital in Maine to offer percutaneous
occlusion of the Left Atrial Appendage (LAA) with the WatchmanTM device for patients
at high risk for stroke and who are considered suitable for short-term Warfarin use but
with reason to seek an alternative (such as high risk of bleeding). Our electrophysiology
team implanted the 100th Watchman device in Maine this year.

ATRIAL FIBRILLATION ABLATION METRICS*
% OF PATIENTS IN NRS (NORMAL SINUS RHYTHM) AT 6-MONTH FOLLOW-UP

94.3%

% OF PATIENTS WITHOUT COMPLICATIONS FOLLOWING ABLATION PRIOR TO
DISCHARGE

96.3%

SURVIVAL AT 6-MONTH FOLLOW-UP AFTER ABLATION PROCEDURE

100%

SYMPTOM-FREE AT 6-MONTH FOLLOW-UP

73.5%

*Source: GWTG AF Registry, Feb. 2018 to Feb. 2019
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WATCHMAN METRICS*

MMC

%
TOTAL

U.S.
HOSPITALS

%
TOTAL

NUMBER OF PATIENTS

42

100%

24,530

100%

ALIVE AT DISCHARGE

42

100%

24,473

99.8%

PATIENTS EVALUATED FOR STROKE RISK USING
THE CHA2DS2-VASC SCORE

42

100%

24,463

99.7%

PATIENTS EVALUATED FOR BLEEDING RISK
USING THE HAS-BLED SCORE

42

100%

24,463

99.7%

LAAO (LEFT ATRIAL APPENDAGE OCCLUSION)
PROCEDURES SUCCESSFUL

39

92.9%

22,370

91.2%

LAAO PROCEDURES SUCCESSFUL EXCLUDING
THOSE PROCEDURES CANCELED

39

95.1%

22,370

93.7%

PATIENTS WITH A MAJOR COMPLICATION
EITHER INTRA OR POST PROCEDURE AND
PRIOR TO DISCHARGE

3

2.1%

647

2.6%

PATIENTS EXPERIENCING A DISABLING OR LIFE
THREATENING BLEEDING EVENT INTRA OR
POST PROCEDURE AND PRIOR TO DISCHARGE

0

0%

60

0.2%

PATIENTS WHO EXPERIENCE A STROKE
(ISCHEMIC OR HEMORRHAGIC), OR SYSTEMIC
EMBOLISM, OR MORTALITY INTRA OR POST
PROCEDURE AND PRIOR TO DISCHARGE

0

0%

83

0.3%

PATIENTS WITH AN ISCHEMIC STROKE
OR SYSTEMIC EMBOLISM INTRA OR POST
PROCEDURE AND PRIOR TO DISCHARGE

0

0%

23

0.1%

MEDIAN LENGTH OF STAY (DAYS)

1

PROCESS METRICS (PROPORTION OF)

OUTCOME METRICS (PROPORTION OF)

1
*Source: NCDR LAAO Registry, Q4 2018 to Q3 2019
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AMERICAN COLLEGE OF CARDIOLOGY NCDR ICD REGISTRY
Since its inception in 2005, the ICD Registry has been the national standard for understanding patient selection, care and
outcomes in patients receiving implantable cardioverter defibrillator (ICD) therapy. The ICD Registry empowers EP physicians
in their decision making by providing them with nationally benchmarked data on patient care and outcomes.

MMC

ACC
NCDR 50TH
PERCENTILE

Q2 2018

TOTAL PROCEDURES

338

COMPOSITE: PROPORTION OF ICD/CRT-D
IMPLANTS PRESCRIBED ALL DISCHARGE
MEDICATIONS FOR WHICH THEY WERE
ELIGIBLE

95.2%

89.5%

98.1%

PROPORTION OF ICD/CRT-D PATIENTS THAT
FULFILL CLASS IA , IIA, OR IIB GUIDELINES

90.9%

84.6%

97.8%

*Source: ICD Registry Rolling Four Quarters Ending Q2 2018

CARDIAC VALVE DISEASE
We offer comprehensive management and treatment options for cardiac valve disease, including aortic, mitral and
tricuspid valve disease. MaineHealth physicians are at the forefront of valve dysfunction and have worked collaboratively
to build upon the traditional surgical approach with emerging less-invasive technologies (such as transcatheter) for
the treatment of both aortic and mitral valves.
Open surgical aortic valve replacement/repair (SAVR) has been the standard for aortic valve disease. Transcatheter
aortic valve replacement (TAVR) is a minimally invasive, catheter-based procedure to replace the aortic valve with severe
aortic stenosis. As an alternative to SAVR, the TAVR procedure was developed for intermediate and high-risk patients
who were not candidates for an open surgical procedure. However, TAVR is now available for lower-risk patients.
Repairing a patient’s mitral valve can return the patient to the quality of life they experienced prior to the onset of mitral
valve disease. Performing these repairs before the disease progresses may prevent future life-threatening conditions.
Less invasive, catheter-based approaches to mitral valve repair are now emerging, and MMC offers eligible patients
a procedure that uses the commercially available MitraClip device indicated for high-risk patients with degenerative
mitral regurgitation.
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MITRAL VALVE CLINIC
MMC formed a mitral valve clinic in 2019 with a vision to provide advanced services spanning the continuum of care and
offering cutting-edge individualized care to patients with primary and secondary mitral valve disease. According to cardiac
surgeon Michael Robich, MD, the MMC clinic will build on the extensive and established experience of both Maine Medical
Partners — MaineHealth Cardiology and Maine Medical Partners — Cardiovascular Surgery as regional leaders in complex
surgical and minimally invasive mitral valve procedures. A multidisciplinary team is working to establish the region’s first
Mitral Center of Excellence to provide even more advanced surgical, minimally invasive and endovascular treatments for
all types of mitral valve disease.

TAVR OUTCOMES
2018

2019*

TAVR PROCEDURES

200

226

IN-HOSPITAL MORTALITY (UNADJUSTED)

0.5%

1.0%

TVT REGISTRY AVERAGE

1.3%

1.0%

STROKE

3.0%

N/A

TVT REGISTRY AVERAGE

1.8%

AORTIC REGURGITATION
(MODERATE TO SEVERE) AT 30 DAYS

0.0%

0.0%

TVT REGISTRY AVERAGE

0.0%

1.0%

SIGNIFICANT CARDIAC EVENTS

0.0%

0.4%

TVT REGISTRY AVERAGE

0.9%

0.5%

Source: STS/ACC/TVT Registry
*Rolling Four Quarters Ending Q2 2019
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AMI PERFUSE
Our AMI PERFUSE (Acute Myocardial Infarction Patients Emergently Re-perfused by Facilities United for
STEMI Excellence) Program has been in place since 2004, with a goal of providing the highest level of care with the
best possible outcomes for patients experiencing an ST-elevation myocardial infarction, regardless of the patient’s
location. Approximately 65% of STEMI patients are initially seen at other hospitals and transferred to MMC for
cardiac catheterization and management. In most cases, these patients are given thrombolytic medication to open
their arteries and restore blood flow to the heart. STEMI patients seen at hospitals close to MMC are stabilized and
transferred to the MMC cardiac catheterization lab for immediate percutaneous coronary intervention (primary PCI).

2018 STEMI
CASES MEETING REPERFUSION GOALS
D2LYTIC LESS THAN 30 MINUTES

70.9%

100 of 141 cases

D2B LESS THAN 90 MINUTES

97.0%

98 of 101 cases

FMC2B LESS THAN 120 MINUTES

88.0%

44 of 50 cases

CORONARY ARTERY DISEASE AND REVASCULARIZATION
MaineHealth coronary revascularization services help people who require heart bypass surgery. We specialize in coronary
artery bypass graft (CABG) procedures and percutaneous coronary intervention, such as coronary angioplasty and stent
placement. Coronary revascularization services help restore blood flow to hearts with diseased arteries (coronary artery disease).
Maine Medical Center doctors performed Maine’s first coronary artery bypass surgery over 40 years ago. Today, MMC
not only performs more of these procedures than any other hospital in Maine, but also more than most hospitals in all New
England. Many coronary artery disease cases can now be diagnosed and treated with a minimally invasive technique known
as cardiac catheterization or “cath.”More than 5,000 cath procedures (such as angiograms, angioplasties and stent placements)
are performed each year in MMC’s state-of-the-art cath lab, making it one of the highest-volume facilities in New England.
INVASIVE / INTERVENTIONAL CARDIOLOGY

CORONARY INTERVENTIONS VOLUME

Our interventional cardiologists provide other
2000
diagnostic services including hemodynamic
1,593
1,553
1,408
assessments for patients with heart failure, valve disease,
1500
pulmonary hypertension and pericardial disease.
1000
Endomyocardial biopsies are performed in select
patients for evaluation of cardiomyopathy and cardiac
500
transplant rejection. The team also performs highrisk percutaneous coronary interventions including
0
2017
2018
2019
left main artery stenosis in patients at increased risk
for surgery, and on those vessels with chronic total
occlusion. A full range of mechanical support devices is available to prevent or treat cardiogenic shock, including
Impella device and extracorporeal membrane oxygenation support with the CardioHelp system.
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The treatment of cardiovascular disease for most patients begins and ends in the clinic where cardiologists and advanced
practice providers evaluate and treat patients. Our providers work collaboratively with primary care and other cardiology
providers in northern New England to ensure patients in our communities have timely access to expert clinical care as
well as outpatient diagnostic services.

In 2019, 1,593 percutaneous coronary interventions (PCI) were performed at MMC. National trends continue to
see lower numbers of PCIs, potentially due to more aggressive and successful medical management of coronary
artery disease versus immediate intervention.

PCI MORTALITY
2017

2018

STEMI PCI

283

329

% TOTAL PCI PROCEDURES

21.40 %

19.70%

ACC-NCDR AVERAGE

16.80%

17.00%

STEMI RISK-ADJUSTED MORTALITY

6.30%

3.21%

ACC-NCDR 50TH PERCENTILE

7.01%

6.45%

PCI EXCLUDING STEMI RISK-ADJUSTED
MORTALITY

0.72%

0.60%

ACC-NCDR 50TH PERCENTILE

1.09%

1.07%

PCI RISK ADJUSTED MORTALITY (ALL)

1.68%

1.04%

ACC-NCDR 50TH PERCENTILE

2.03%

1.96%

Source: ACC-NCDR American College of Cardiology National Cardiovascular Data Registry
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CARDIAC IMAGING AND DIAGNOSTICS
Our Cardiac Imaging and Diagnostics Program provides nationally recognized services to patients. The
multidisciplinary team of physicians, technologists and staff provide state-of-the-art diagnostic services utilizing
cutting-edge multimodality technologies. We perform the highest volume of services in the state, including the
management of complex, unusual cardiovascular diseases as well as common problems, all with a focus on the
patient. Our specialists have expertise in imaging for ischemic, valvular, vascular and congenital cardiovascular
disease. Additionally, cardiac MRI, PET and CT services are offered. MMC has the only dedicated PET perfusion
program in northern New England, imaging sarcoidosis and myocardial viability.
Many services are available at regional hospitals across our health system so that heart patients can access care
close to home.
Maine Medical Partners —
 MaineHealth Cardiology was one of the first practices in Maine to offer in-office
insertion of the Reveal LINQ Insertable Cardiac Monitor, an advanced cardiac monitor that allows physicians
to continuously and wirelessly monitor a patient’s heartbeat for up to three years. Physicians typically implant
cardiac monitors in the hospital setting due to past reimbursement guidelines; however, new reimbursement
coverage allows us to perform the procedure in the office setting. In-office procedures are another way for patients
to gain access to the long-term monitoring they need.
SPORTS CARDIOLOGY
The MaineHealth Sports Cardiology Program is the only one in the state dedicated to the care of the athlete’s
heart. We offer specialized cardiac care to athletes and highly active individuals, whether they have symptoms
suggestive of cardiovascular disease or an established cardiovascular diagnosis. Our goal is to keep athletes
healthy so they can remain active in sports. In addition to training in heart disease diagnosis and treatment, our
sports cardiologists have specialized expertise in the physical demands of competitive sports and the psychology
of athletes. The program offers a full spectrum of diagnostic testing, including cardiac imaging, comprehensive
physiologic assessment using cardiopulmonary exercise testing and access to other cardiac services. We provide
recommendations for appropriate activity levels and symptom management for each athlete — helping them
make decisions about when and how they can safely resume participation in their sport.
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Vascular tech Ellen Bacchiocchi uses ultrasound on a heart patient

Aimee Reilly, LCSW

HEART CARE BEATS WITH EMOTIONAL SUPPORT
New program is valuable after a heart event
MMC physicians work hard every day to restore the physical health of patients with heart
disease. According to Marco Diaz, MD, the “emotional challenges of being diagnosed with
and living with heart conditions can be life-altering as well.” Aimee Reilly, LCSW, is helping
patients, family members and physicians learn about how to restore emotional health. “Her
expertise has ensured that no one faces heart disease alone or without the support they need,”
said Dr. Diaz.

In our integrated program, Aimee communicates frequently with cardiologists about patients’ questions, concerns and
symptoms, and updates them on patients’ behavioral health treatment goals. Research has shown that major depressive
disorder rates for patients following myocardial infarction are approximately 20%, about triple the rate for the general
population. A patient with depression may not be taking their medications as prescribed, may not be practicing a healthy
lifestyle, or could be utilizing smoking or alcohol to cope — all of which could negatively impact the patient’s cardiac
condition. “It is important for patients to know that significant changes in mood following cardiac events is common,
treatable and equally as important to address as their physical needs,” Aimee explained. “The health care industry
increasingly recognizes the importance of behavioral health in connection with a patient’s medical well-being. Our program
expanded into cardiology as cardiologists recognized their patients’ need for behavioral support.”
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Walk with a Doc, a national program started by a cardiologist, was introduced
in May 2019 to support patients in cardiac rehabilitation at Turning Point.
Before monthly walks, our providers offer education sessions about heart
issues. Pictured Jeffrey Rosenblatt, MD, walks with patient in Scarborough.

CARDIAC REHABILITATION
Cardiac rehabilitation (or rehab) programs help people with heart issues make healthy lifestyle choices to reduce
the risk of future heart problems. Services include nutrition counseling, graduated exercise training, stress
reduction education and more. MaineHealth offers cardiac rehab services at multiple locations across the state.
MMC’s cardiac rehabilitation offering, Turning Point, is an outpatient program located at Maine Medical Partners
— MaineHealth Cardiology in Scarborough. The program consists of four phases:
• Phase 1 is a visit to inpatients at MMC for education on risk-factor modification and outpatient cardiac rehab
program enrollment.
• Patients return to our facility in Scarborough, or the closest facility our team can assign, to initiate Phase 2, a
program of outpatient services that includes education and exercise sessions three times per week.
• We offer a Phase 3 outpatient program to Phase 2 graduates, or others with specific medical conditions who
may benefit from a medically supervised exercise program.
• Finally, we encourage all our patients to participate in Phase 4, a program of independent exercise at a communitybased fitness center or gym.
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(SELF PAY) VISITS
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VASCULAR REHAB VISITS

TOTAL VISITS

PARTICIPATION DATA: NATIONAL VS LOCAL

72
%

80%
FY19 MMC TURNING POINT CARDIAC REHAB

70%

2016-2017 MEDICARE BENEFICIARIES

60%
44

%

50%

27
%

24
%

24
%

30%

24
%

40%

20%
10%
0%

ENROLLMENT RATE

ENROLLMENT WITHIN 21 DAYS OF DISCHARGE

COMPLETION RATE

Source: Circ Cardiovasc Qual Outcomes 2020; 13:e005902. DOI: 10.1161/
CIRCOUTCOMES.119.005902 January 2020
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MMC cardiac surgeon Walter
DeNino, MD, onboard LifeFlight.
LifeFlight and MMC’s ECMO
team created protocols
and procedures, along with
developing a standardized team
for specialized transports.

CARDIOVASCULAR SURGERY
MaineHealth offers the state’s most comprehensive resources for cardiac surgery. Our highly skilled cardiothoracic
surgeons provide each patient with an individualized plan of care to best suit that patient’s needs. The cardiac surgical
team consists of cardiac surgeons who work with cardiac anesthesiologists, perfusionists, physician assistants, cardiac
operating room staff and nursing and critical care staff who care for the patient after the operation. Our program
has been recognized by U.S. News & World Report as a Best Regional Hospital and “high performing” in bypass
and aortic valve surgery.
• Other areas of expertise include our elective and emergent thoracic aortic procedures, mechanical circulatory
support and surgery for atrial fibrillation. We manage all aspects of this progressive disease, including acute and
chronic cases, and patients with known or suspected connective tissue diseases.

• MMC is the only hospital in Maine performing EKG-gated CT angiography, which offers the most accurate
assessment of the thoracic aorta.
• High surgical volume has been shown to improve the outcomes in transcatheter valve procedures. Cardiac
surgeons at MMC have unparalleled experience in heart valve surgery, performing more of these surgical
procedures than at any other hospital in Maine.
• The advanced valve team is comprised of cardiologists and surgeons who work closely with heart failure
specialists, radiologists and palliative care staff to deliver personalized care whether that involves surgery,
transcatheter treatments or optimal medical management. The team is available to assess patients who are highor prohibitive-risk candidates for intervention.
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CARDIAC SURGERY BY TYPE

ISOLATED
CORONARY
ARTERY BYPASS
GRAFT (CABG)

2017

2018

2019

481

483

523

CARDIAC SURGERY OUTCOMES
RISK-ADJUSTED OPERATIVE
MORTALITY
2017

2018

ISOLATED
CORONARY ARTERY
BYPASS GRAFT
(CABG)

2.80%

2.30%

STS* AVERAGE

2.30%

2.20%

ISOLATED
AORTIC VALVE
REPLACEMENT
(AVR)

0.00%

1.30%

STS AVERAGE

2.00%

1.90%

AVR + CABG

1.40%

2.10%

STS AVERAGE

3.70%

3.80%

CAB +
AORTIC VALVE
REPLACEMENT
(AVR)

69

CAB + MITRAL
VALVE
REPLACEMENT
(MVR)

12

CAB + MITRAL
VALVE REPAIR

22

17

23

ISOLATED
AORTIC VALVE
REPLACEMENT

85

81

86

TRANSCATHETER
AORTIC VALUE
REPLACEMENT
(TAVR)

159

193

239

ISOLATED
MITRAL VALVE
REPLACEMENT

19

10

19

AORTIC VALVE
REPLACEMENT
+ MITRAL VALVE
REPLACEMENT

7

8

7

ISOLATED MITRAL
VALVE REPAIR
(MVRP)

3.70%

1.70%

MITRAL VALVE
REPAIR

37

57

63

STS AVERAGE

1.20%

1.10%

OTHER

252

201

213

TOTAL
CORONARY
ARTERY BYPASS
GRAFT

584

585

631

MVRP + CABG

0.00%

11.10%

STS AVERAGE

5.30%

4.50%

TOTAL VALVE

410

77

8

451

82

3

522

*The Society of Thoracic Surgeons
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Elizabeth Blazick, MD, Maine
Medical Partners — Surgical
Care, discusses carotid artery
disease with a patient. We provide
patients with carotid artery
disease access to comprehensive,
state-of-the-art treatments
including carotid endarterectomy,
artery stenting (trans-femoral and
TCAR), artery aneurysm surgery,
body tumor surgery and artery
fibromuscular dysplasia.

VASCULAR DISEASE AND SURGERY
AORTIC, PERIPHERAL AND
INTERVENTIONAL RADIOLOGY

VASCULAR VOLUMES

Our vascular services staff is committed to continuous
improvement. To aid with this effort, we subscribe to nine
registries that allow us to benchmark our performance
against our peers across the U.S.: Carotid Artery
Stent, Carotid Endarterectomy, Endovascular AAA
Repair, Lower Extremity Amputation, Infra-inguinal
Bypass, Supra-inguinal Bypass, Open AAA, Peripheral
Vascular Intervention and Thoracic and Complex

1200

EVAR (including Endovascular Thoracic Stenting and
treatment for penetrating aortic ulcers and dissections).
An important aspect of improving the quality of vascular
care is achieved through a commitment to seeing the
patient at a long-term follow-up visit, nine to 21 months
after one of these procedures.
Patients are treated in state-of-the-art facilities, such as
our cutting-edge hybrid operating suite, and have access
to the most advanced treatments, including clinical trials
of new medications, devices and surgical techniques.
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MaineHealth offers the most-advanced vascular surgery services in Maine — both open and endovascular. Our team of
highly skilled specialists includes cardiologists, vascular surgeons, interventional radiologists and diagnostic radiologists,
all working together to evaluate and treat each patient. Vascular surgery includes treatment for thoracic aortic aneurysms,
abdominal aortic aneurysms and aneurysms of the arteries.

QUALITY MEASURES
2018

2019

ALL AAA REPAIRS / DEATH DURING HOSPITALIZATION

86 / 5.8% (5)

70 / 2.9% (2)

ALL CAROTID REVASCULATION / NEW STROKE

203 / 3.4% (7)

256 / 2.7% (7)

LOWER EXTREMITY / AMPUTATION DURING HOSPITALIZATION

N/A

499 / 2.9% (9)

Physician Assistant Julie Savatelli in the Vein Clinic, Scarborough.

NEW JOINT
VEIN PROGRAM
Our medical Vein Clinic
in southern Maine is a
joint partnership between
Maine Medical Partners —
MaineHealth Cardiology
and Maine Medical
Partners — Surgical
Care/Vascular Surgery.
Services include laser vein
ablation, radiofrequency
vein ablation, ClariVein,
phlebotomy, ligation and
sclerotherapy.
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Pictured, left to right,
Julie Salvatelli, PA;
Kimberly Malka, MD;
Nathan Aranson, MD;
Cameron Donaldson, MD; and
Samip Vasaiwala, MD.

CARE TEAMS—ADVANCED PRACTICE PROVIDERS, CARDIAC ANESTHESIOLOGY AND NURSING
Advanced practice providers (APPs), including nurse practitioners and physician assistants, are an integral
component of the ambulatory and hospital care teams within Cardiovascular Services. Team-based care is paramount
to transforming cardiovascular care and improving heart health. As more patients receive team-based care from
both a physician and an APP, research indicates the joint approach may improve quality of care as well as access to
care for patients.
Cardiac surgery APPs provide 24/7 comprehensive care in the operating room as first assistants, in the cardiothoracic
intensive care unit and in the cardiac surgery step down unit. Vascular surgery APPs provide care for patients in the
hospital setting, including OR first assist and patient care in the surgical units as well as pre- and post-hospital care
in the ambulatory setting. Cardiology APPs provide direct care and support to cardiology inpatients (both medical
and procedural), while a separate group of APPs provides direct care to cardiology patients seen in the cardiology
ambulatory setting.
The cardiac anesthesiology group is comprised of physicians providing around-the-clock specialty anesthesia services
for our cardiac surgery patients. All are experts in managing the special needs of the cardiac patient who requires
anesthetic care. Furthermore, our cardiac anesthesiologists have proven special competence in advanced intraoperative
echocardiography and provide real-time intraoperative imaging services. Our anesthesiologists work closely with
cardiac surgeons and cardiologists in order to ensure patient safety and well-being in the perioperative period.
Cardiovascular nurses and the interprofessional team work
to create an environment rich in quality-care improvements,
professional experience and progressive learning opportunities.
A shared governance model ensures that nurses and
interprofessionals who practice patient care have a strong voice
in decisions that affect their practice. As a three-time Magnetrecognized facility, MMC is in the top two percent in the country
and our nurses pursue excellence in their care of patients.
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OR team (with Surgical Technologist Susan Nelson
facing) preparing for a pediatric cardiac surgery

PATIENT CHANGES CAREER, INSPIRED BY THE
DOCTOR WHO SAVED HER LIFE
Monica Salamone is a mother of two, and it wasn’t long after
the birth of her younger son that her life took a dramatic
turn. Monica was living with a congenital heart condition
that hadn’t caused any major issues. One day at home she
collapsed, and her husband called 911. Monica’s heart was
struggling to beat. Within her chest, the inner layer of the
aorta (the large blood vessel branching off the heart) had
torn. Blood was surging through the tear, causing the inner
and middle layers of the aorta to separate — a very serious
and usually fatal condition called an aortic dissection.
Because Monica needed emergency open-heart surgery,
she was transported from Southern Maine Health Care
(SMHC) to MMC by ambulance. Cardiothoracic surgeon
Scott Buchanan, MD, performed Monica’s operation. He later told her the team at SMHC and the paramedics who
responded to her husband’s 911 call had done everything perfectly right, and that their actions were key to saving her
life. Monica benefitted from a coordinated system of care within the MaineHealth family of providers.
Monica had a chance to go back to school and decided to change the course of her career. She recently became a
cardiovascular radiologic technologist and part of the MMC cardiovascular team. Monica now works alongside the
doctor who saved her life.

RESEARCH HIGHLIGHTS
Cardiovascular Services at MaineHealth is a leader in education and research in northern New England. MMC has
a long tradition of excellence in education with a full complement of residency and fellowship programs, along with
ACGME-accredited training programs in Cardiovascular Medicine and Vascular Surgery. Our physicians, nurses and
scientists participate in clinical trials. We are actively involved in multidisciplinary research efforts in basic and translational
science at the Maine Medical Center Research Institute (MMCRI), population science and epidemiology at the Center
for Outcomes Research (CORE) and education research at the Maine Institute for Teaching Excellence (MITE). This
year our highlights include:
• Access to Cardiac Clinical Trials in Rural Areas								
Robert Kramer, MD, Director of Cardiac Surgery Research and Quality Improvement at MMC, and Alexander
Iribarne, MD, MS, cardiac surgeon and Director of Cardiac Surgery Research at Dartmouth-Hitchcock Medical
Center (DHMC) are principal investigators on a $3.9-million grant from the National Institute of Health’s
National Heart, Lung and Blood Institute (NHLBI). This grant will establish a collaborative network to increase
access to cardiac surgery clinical trials among rural populations. MMC and DHMC are now linked Clinical
Research Centers that support the NIH Cardiothoracic Surgical Trials Network. The grant will have a significant
impact on rural cardiac surgery patients in Maine and New Hampshire, states with the oldest populations in the
nation, according to the most recent U.S. Census data. Maine is also the state with the highest percentage of its
population living in rural or non-metropolitan areas. People residing in rural areas of northern New England
have higher-than-average rates of cardiovascular disease.
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• $1.9M Awarded to Study Cardiac Cell Therapy in Maine 							
Medical Center Chief Academic Officer, Doug Sawyer, MD, PhD, and MMCRI Faculty Scientist Calvin Vary,
PhD, are the principal investigators on a $1.9-million grant from the NHLBI to study how certain adult stem
cells might be used to reverse heart failure when injected into the heart. The research team is looking into whether
certain kinds of heart cells might be more effective than others in regenerating heart tissue when injected into
a failing heart.
• Anti-Aging Diets Impact Vascular Health 									
Obesity is a risk factor for the accelerated development of cardiovascular disease, and a steady increase in obesity,
particularly in youth, has made this condition a major public health problem. MMCRI faculty scientist Lucy
Liaw, PhD is taking a closer look at diets and cardiovascular disease, thanks to her recent Transformational
Project Award from the American Heart Association (AHA). The major problem the lab will address is why
obesity and fat expansion lead to greater occurrence or severity of vascular disease. This research will study how
anti-aging diets impact fat surrounding blood vessels and vascular health. Long-term results from studies like
Dr. Liaw’s could lead to potential therapies to increase health and reverse the effects of cardiovascular disease.
• Can Resveratrol Help Patients with Diabetes and Heart Disease?						
Diabetes prevents efficient metabolism of fuel, causes inflammation and vascular disease that blocks normal
blood flow and inhibits the function of the heart after injury. These changes make diabetics more susceptible to
heart attacks and heart failure. AHA leads the fight against diabetes and heart disease. MMC cardiac surgeon
Michael Robich, MD, received a Mentored Clinical & Population Research Award from the AHA, with Dr.
Doug Sawyer serving as mentor. This project is a unique collaboration among cardiologists, cardiac surgeons
and other scientists. In the first phase of this study, physicians have been safely collecting tissue from the hearts
of patients undergoing heart surgery. In 2019 the second phase of the study began, which included enrolling
patients to examine how resveratrol changes the metabolic profile of the heart. Understanding how the heart is
impacted by diabetes and reversing its negative effects could lead to decreased rates of heart failure and death
in diabetic patients and could offer new treatment options.
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COORDINATION OF CARE KEEPS PATIENT MOVING
John “Kenny” Kramer is the kind of guy who just doesn’t stop moving. He never had any major health issues until one day,
after carrying ten 40-pound bags of wood pellets into his shed, he collapsed at the kitchen sink. Almost immediately, Kenny
regained consciousness. But his wife arranged for an ambulance to take him to the SMHC Emergency Department for a CT
scan. Once the scan was complete, Dr. Sarah Shepherd determined Kenny was suffering from a large, ruptured abdominal
aortic aneurysm, at which point he was airlifted to MMC for emergency surgery led by vascular surgeon Paul Bloch, MD.
Kenny had an enlarged blockage in his abdomen that was preventing crucial blood flow, and it needed attention right away.
The surgery saved Kenny’s life. The next morning he was on his way home, and within a month he was back to walking
two miles a day. “I had no symptoms whatsoever,” Kenny says. “I remember going to the ED in Sanford, and that’s about
it until I spoke with Dr. Bloch at MMC. The coordination between the care teams was wonderful.”
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PROVIDER RESOURCES AND RECOGNITION
MaineHealth is committed to knowledge sharing and the ongoing
discussion of our cardiovascular best practices, clinical guidelines, research
and outcomes. In the past year, we’ve organized valuable resources for both
our regional network of cardiovascular care providers and for other health
care professionals who are interested in referring a patient to our care. For
more information, visit:
https://mainehealth.org/services/cardiovascular/provider-resources
• Care protocols and referral guidelines
• Innovation videos
• Provider interviews and case studies
• Outcomes reporting
• Provider education

MAINEHEALTH HAS RECEIVED
SYSTEMWIDE ACCREDITATION FOR
OUR ECHOCARDIOGRAPHY SERVICE
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MAINE MEDICAL CENTER
RECOGNITION

PRACTICE DIRECTORY
CARDIOLOGY

VASCULAR SURGERY

MAINE MEDICAL PARTNERS —
MAINEHEALTH CARDIOLOGY

MAINE MEDICAL PARTNERS —
SURGICAL CARE (VASCULAR)

Scarborough

207-885-9905

Lewiston

207-777-5300

Augusta

207-430-4321

Rockport

207-596-6410

Waterville

207-872-1800

207-885-9905

207-662-0909

MAINE MEDICAL PARTNERS —
CARDIOVASCULAR SURGERY
207-773-8161

207-885-9905

207-779-3120

SOUTHERN MAINE HEALTH CARE
(MAINE MEDICAL PARTNERS)
Biddeford/Sanford

207-282-3666

CARDIOVASCULAR SURGERY

Portland/Lewiston

FRANKLIN MEMORIAL HOSPITAL
(MAINE MEDICAL PARTNERS)
Farmington

Biddeford

Scarborough

MEMORIAL HOSPITAL
(MAINE MEDICAL PARTNERS)
North Conway, NH

SOUTHERN MAINE HEALTH CARE VASCULAR
SERVICES

207-563-4811

MAINE MEDICAL PARTNERS
CARDIOLOGY, ST. ANDREW’S CAMPUS
Boothbay

207-662-8900

MAINE MEDICAL PARTNERS VEIN PROGRAM

LINCOLN MEDICAL PARTNERS
CARDIOLOGY, MILES CAMPUS
Damariscotta

Portland/Lewiston/
Scarborough

CONGENITAL HEART
MAINE MEDICAL PARTNERS —
CONGENITAL HEART
Portland

207-883-5532

207-282-3666

WALDO COUNTY MEDICAL PARTNERS
CARDIOVASCULAR MEDICINE
Belfast

207-505-4675

STEPHENS MEMORIAL, WESTERN MAINE
HEALTH (MAINE MEDICAL PARTNERS)
Norway

207-885-9905

REDINGTON-FAIRVIEW GENERAL HOSPITAL
(MAINE MEDICAL PARTNERS)
Skowhegan

207-872-1800

MID COAST CARDIOLOGY
Brunswick

207-729-7939
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